NCT00202007 - Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

July 31, 2005

Conditions

Schizophrenia

Interventions

DRUG

Aripiprazole tablet, 5-30mg/day, oral, 6 weeks

DRUG

Risperidone tablet, 1-6mg/day, oral, 6 weeks

Trial Locations (6)

Guangzhou Brain Hospital, Guangzhou

Psychiatry Dept. People's Hospital, Wuhan University, Wuhan

Mental Health Hospital, Nanjing Medical University, Nanjing

Anding Hosp. Capital University of Medical Science, Beijing

Institute of Mental Health, Peking University, Beijing

Shanghai Mental Health Center, Shanghai